Axogen Inc Stock
Axogen Inc Stock
Axogen Inc shows a slight decrease today, losing -€0.190 (-0.530%) compared to yesterday.
Pros and Cons of Axogen Inc in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Axogen Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Axogen Inc | -0.530% | 0.174% | -4.478% | 250.863% | 23.429% | 326.667% | 122.968% |
| MicroVision Inc | -9.380% | -31.372% | -35.197% | -63.548% | -50.207% | -91.877% | -97.760% |
| Simulations Plus | 2.900% | 3.759% | 9.524% | -62.703% | -10.390% | -62.703% | -67.453% |
| Fonar Corp. New | 0.620% | 1.242% | 1.242% | 29.365% | 4.487% | 3.165% | 10.135% |
Comments
News
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam
AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
DAFNA Capital Management cut its holding in Axogen (NASDAQ:AXGN) by 265,456 shares in the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February
